Kezar Life Sciences Inc (KZR)

Jul 23, 2025

Is Kezar Life Sciences Inc. a good long term investmentOutstanding capital appreciation - Autocar Professional

Jul 23, 2025

Jul 22, 2025

What analysts say about Kezar Life Sciences Inc. stockRapid market gains - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Kezar Life Sciences Inc. Stock Analysis and ForecastAccelerated capital growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Kezar Life Sciences Inc. stock priceAccelerated wealth expansion - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

When (KZR) Moves Investors should Listen - news.stocktradersdaily.com

Jul 22, 2025

Jul 19, 2025

How Kezar Life Sciences Inc. stock reacts to Fed policy changesBreakout Confirmation Tool - beatles.ru

Jul 19, 2025

Jul 19, 2025

Kezar Life Sciences’ (KZR) Neutral Rating Reiterated at HC Wainwright - Defense World

Jul 19, 2025

Jul 18, 2025

How high can Kezar Life Sciences Inc. stock price go in 2025Chart Based Entries - Newser

Jul 18, 2025

Jul 17, 2025

HC Wainwright & Co. Maintains Neutral Rating on Kezar Life Sciences - AInvest

Jul 17, 2025

Jul 17, 2025

In Brief: Kezar Plots Lupus Revival For Zetomipzomib As FDA Lifts Hold On Hepatitis Trial - insights.citeline.com

Jul 17, 2025

Jul 16, 2025

FDA Lifts Pause On Kezar's Liver Drug Trial—Next Stop Lupus Study - Benzinga

Jul 16, 2025

Jul 16, 2025

FDA lifts partial hold on Kezar’s zetomipzomib trial - The Pharma Letter

Jul 16, 2025

Jul 16, 2025

KZR: Kezar Life Sciences Maintains Neutral Rating by HC Wainwrig - GuruFocus

Jul 16, 2025

Jul 15, 2025

Kezar Says US FDA Lifts Partial Clinical Hold on Zetomipzomib Trial in Autoimmune Hepatitis; Shares Rise After Hours - MarketScreener

Jul 15, 2025

Jul 15, 2025

Kezar Life Sciences stock gains after FDA lifts partial clinical hold - Investing.com Canada

Jul 15, 2025

Jul 15, 2025

Organon & Co. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 22, 2025 to Discuss Your RightsOGN - The Globe and Mail

Jul 15, 2025

Jul 15, 2025

Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis - Business Wire

Jul 15, 2025

Jul 15, 2025

What makes Kezar Life Sciences Inc. stock price move sharplyProven Trading Plan - Newser

Jul 15, 2025

Jul 15, 2025

Why Kezar Life Sciences Inc. stock attracts strong analyst attentionFree Predictions - Newser

Jul 15, 2025

Jul 15, 2025

How BPYPP stock performs during market volatilityExpert Trading Flow - Newser

Jul 15, 2025

Jul 15, 2025

How Kezar Life Sciences Inc. stock performs during market volatilityStrong Return Daily Alerts - Newser

Jul 15, 2025

Jul 15, 2025

Consensus Cloud Secures $225 Million Credit Facility - The Globe and Mail

Jul 15, 2025

Jul 15, 2025

How Li Bang International Corporation Inc. stock performs during market volatilitySwing Trade Signals - Newser

Jul 15, 2025

Jul 12, 2025

Where Will ARK 21Shares Bitcoin ETF Be in 5 Years? - The Globe and Mail

Jul 12, 2025

Jul 11, 2025

Bragg Gaming Expands U.S. Presence with Fanatics Casino Launch - The Globe and Mail

Jul 11, 2025

Jul 11, 2025

Where are the Opportunities in (KZR) - news.stocktradersdaily.com

Jul 11, 2025

Jul 11, 2025

SemiLEDs Reports Third Quarter Fiscal Year 2025 Financial Results - The Globe and Mail

Jul 11, 2025

Jul 03, 2025

Kezar Life Sciences (NASDAQ:KZR) Shares Up 2% – Time to Buy? - Defense World

Jul 03, 2025

Jul 01, 2025

(KZR) Proactive Strategies - news.stocktradersdaily.com

Jul 01, 2025

Jun 30, 2025

Kezar Life Sciences, Inc.(NasdaqCM: KZR) added to Russell Microcap Value Index - MarketScreener

Jun 30, 2025

Jun 23, 2025

Kezar Shareholders Re-Elect Board, Approve Pay Package in 2025 Vote | KZR SEC FilingForm 8-K - Stock Titan

Jun 23, 2025

Jun 11, 2025

Kezar Life Sciences, Inc. (NASDAQ:KZR) Shares Sold by Millennium Management LLC - Defense World

Jun 11, 2025

Jun 10, 2025

Two Sigma Investments LP Cuts Holdings in Kezar Life Sciences, Inc. (NASDAQ:KZR) - Defense World

Jun 10, 2025

Jun 10, 2025

(KZR) On The My Stocks Page - news.stocktradersdaily.com

Jun 10, 2025

Jun 10, 2025

FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors - The Manila Times

Jun 10, 2025

Jun 04, 2025

Northern Trust Corp Reduces Stock Position in Kezar Life Sciences, Inc. (NASDAQ:KZR) - Defense World

Jun 04, 2025

May 29, 2025

Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference 2025 - BioSpace

May 29, 2025